135 related articles for article (PubMed ID: 34858321)
21. Familial moyamoya disease in two Turkish siblings with same polymorphism in RNF213 gene but different clinical features.
Bayram AK; Yilmaz E; Per H; Ito M; Uchino H; Doganay S; Houkin K; Unal E
Childs Nerv Syst; 2016 Mar; 32(3):569-73. PubMed ID: 26277359
[TBL] [Abstract][Full Text] [Related]
22. Multiple endocrine neoplasia 2A (MEN 2A) syndrome.
Breza J; Breza J
Bratisl Lek Listy; 2018; 119(2):120-125. PubMed ID: 29455549
[TBL] [Abstract][Full Text] [Related]
23. RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.
Matsuda Y; Mineharu Y; Kimura M; Takagi Y; Kobayashi H; Hitomi T; Harada KH; Uchihashi Y; Funaki T; Miyamoto S; Koizumi A
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1841-1847. PubMed ID: 28506590
[TBL] [Abstract][Full Text] [Related]
24. Elevated basal serum levels of calcitonin and simultaneous surgery of MEN2A-specific tumors.
Tang HX; Yang H; Li F; Cao ZL; Huang YT; Qi XP
Neoplasma; 2021 Sep; 68(5):1098-1106. PubMed ID: 34156257
[TBL] [Abstract][Full Text] [Related]
25. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
[TBL] [Abstract][Full Text] [Related]
26. Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1.
Phi JH; Choi JW; Seong MW; Kim T; Moon YJ; Lee J; Koh EJ; Ryu SK; Kang TH; Bang JS; Oh CW; Park SS; Lee JY; Wang KC; Kim SK
J Neurosurg Pediatr; 2016 Jun; 17(6):717-22. PubMed ID: 26849809
[TBL] [Abstract][Full Text] [Related]
27. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
Frank-Raue K; Raue F
Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
[TBL] [Abstract][Full Text] [Related]
28. Multiple endocrine neoplasia type 2A in an Iranian family: clinical and genetic studies.
Ghazi AA; Bagheri M; Tabibi A; Sarvghadi F; Abdi H; Hedayati M; Pourafkari M; Tirgari F; Yu R
Arch Iran Med; 2014 May; 17(5):378-82. PubMed ID: 24784869
[TBL] [Abstract][Full Text] [Related]
29. Bilateral pheochromocytoma with ganglioneuroma component associated with multiple neuroendocrine neoplasia type 2A: a case report.
Efared B; Atsame-Ebang G; Tahirou S; Mazaz K; Hammas N; El Fatemi H; Chbani L
J Med Case Rep; 2017 Aug; 11(1):208. PubMed ID: 28760150
[TBL] [Abstract][Full Text] [Related]
30. Effect of Lenvatinib on a Patient with Medullary Thyroid Carcinoma Liver Metastasis Caused by Multiple Endocrine Neoplasia Type 2A.
Sato H; Saito Y; Inomoto C; Suzuki Y
Tokai J Exp Clin Med; 2020 Apr; 45(1):18-23. PubMed ID: 32219805
[TBL] [Abstract][Full Text] [Related]
31. Ventricular thrombosis in Sipple's syndrome.
Pishdad GR
South Med J; 2000 Nov; 93(11):1093-5. PubMed ID: 11095560
[TBL] [Abstract][Full Text] [Related]
32. De Novo Development of Moyamoya Disease in an Adult Female with a Genetic Variant of the RNF-213 Gene: Case Report.
Tashiro R; Fujimura M; Niizuma K; Endo H; Sakata H; Sato-Maeda M; Tominaga T
J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):e8-e11. PubMed ID: 27789153
[TBL] [Abstract][Full Text] [Related]
33. Pheochromocytoma as the first manifestation of MEN2A with RET mutation S891A: report of a case.
Hibi Y; Ohye T; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Uchino S; Kosugi S; Kurahashi H; Iwase K
Surg Today; 2014 Nov; 44(11):2195-200. PubMed ID: 24449023
[TBL] [Abstract][Full Text] [Related]
34. A MEN2A family with two asymptomatic carriers affected by unilateral renal agenesis.
Hibi Y; Ohye T; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Kurahashi H; Iwase K
Endocr J; 2014; 61(1):19-23. PubMed ID: 24152999
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow up of a "sporadic" unilateral pheochromocytoma revealing multiple endocrine neoplasia MEN2A-2 in an elderly woman.
Weinhäusel A; Behmel A; Ponder BA; Haas OA; Niederle B; Gessl A; Vierhapper H; Pfragner R
Endocr Pathol; 2003; 14(4):375-82. PubMed ID: 14739494
[TBL] [Abstract][Full Text] [Related]
36. Genetic analysis and clinical investigation of a pedigree with multiple endocrine neoplasia type 2A: A case report.
Zou HJ; Li YS; Shan ZY
Oncol Lett; 2016 Oct; 12(4):2657-2659. PubMed ID: 27698838
[TBL] [Abstract][Full Text] [Related]
37. The clinical spectrum of multiple endocrine neoplasia type 2a caused by the rare intracellular RET mutation S891A.
Schulte KM; Machens A; Fugazzola L; McGregor A; Diaz-Cano S; Izatt L; Aylwin S; Talat N; Beck-Peccoz P; Dralle H
J Clin Endocrinol Metab; 2010 Sep; 95(9):E92-7. PubMed ID: 20554711
[TBL] [Abstract][Full Text] [Related]
38. Clinical Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by the D631Y RET Mutation.
Ospina NS; Maraka S; Donegan D; Morris JC
Thyroid; 2017 Oct; 27(10):1332-1334. PubMed ID: 28747092
[TBL] [Abstract][Full Text] [Related]
39. [The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].
Zhou YL; Zhu SX; Li JJ; Liu JB; Yin M; Xiao BY; Yu CL; Wang LM; Gu LQ; Cui B; Ning G; Li XY; Zhao YJ
Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):466-70. PubMed ID: 17663821
[TBL] [Abstract][Full Text] [Related]
40. A 6-Base Pair in Frame Germline Deletion in Exon 7 Of RET Leads to Increased RET Phosphorylation, ERK Activation, and MEN2A.
Latteyer S; Klein-Hitpass L; Khandanpour C; Zwanziger D; Poeppel TD; Schmid KW; Führer D; Moeller LC
J Clin Endocrinol Metab; 2016 Mar; 101(3):1016-22. PubMed ID: 26765577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]